3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
36
Leukemia
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Gastrointestinal Stromal Tumors
13
Leukemia, Myeloid, Chronic-Phase
12
Leukemia, Myeloid
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Philadelphia Chromosome
5
Blast Crisis
5
Sarcoma
4
Recurrence
4
Glioblastoma
4
Carcinoma, Non-Small-Cell Lung
4
Bone Marrow Diseases
4
Ovarian Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Breast Neoplasms
3
Stomach Neoplasms
2
Polycythemia Vera
2
Neurofibromatoses
2
Neoplasms by Histologic Type
2
Neoplasms
2
Neoplasm Metastasis
2
Myeloproliferative Disorders
2
Meningioma
2
Interventions
Darbepoetin alfa
2
piperine
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Whole-Body Irradiation
1
Urination
1
Therapeutics
1
Sucrose
1
Rituximab
1
Phenytoin
1
Peripheral Blood Stem Cell Transplantation
1
Oxycodone
1
Mycophenolic Acid
1
Morphine
1
Methotrexate
1
Methadone
1
Metformin
1
KW-2478
1
Hsp90 inhibitor KU757
1
Granulocyte Colony-Stimulating Factor
1
Gene Expression Profiling
1
Fentanyl
1
Fatty Acids, Omega-3
1
Epoetin Alfa
1
Early Intervention, Educational
1
Cyclosporine
1
Curcumin
1
Celecoxib
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Monoclonal Gammopathy of Undetermined Significance
×
Imatinib Mesylate
×
Clear all
No trials found.